Spearheading Singapore's Biomedical Sciences initiative EDB's BMS group and Bio*One Capital, as well as A*STAR's BMRC work in close partnership. The goal is to develop the BMS cluster - comprising pharmaceuticals, medical technology, biotechnology and healthcare services - into a key pillar of the Singapore economy. The three groups adopt an integrated approach to develop Singapore's industrial, intellectual and human capital to support the BMS initiative. This integrated approach involves various initiatives such as supporting the industry, establishing the right infrastructure, providing venture capital support and strengthening manpower capabilities.

Economic Development Board The Singapore Economic Development Board (EDB) is the lead agency that plans and executes strategies to develop Singapore as a compelling global hub for business and investment. It enables multinational and Singapore-based companies to establish value-creating operations in both the manufacturing and internationally tradeable services sectors. The EDB Biomedical Sciences Group (EDB BMSG) is responsible for the development of the Biomedical Sciences industry. The BMS Group works closely with A*STAR's Biomedical Research Council (BMRC), Bio*One Capital and other agencies to develop human, intellectual, and industrial capital in Singapore, in support of the Biomedical Sciences industry.

Agency for Science Technology and Research (A*STAR) A*STAR is Singapore's lead agency for fostering world-class scientific research and talent for a vibrant knowledge-based Singapore. The agency actively nurtures public sector research and development in Biomedical Sciences, Physical Sciences and Engineering, with a particular focus on fields essential to Singapore's manufacturing industry and new growth industries. It oversees 12 research institutes and supports extramural research with the universities, hospital research centres and other local and international partners. At the heart of this knowledge intensive work is human capital. Top local and international scientific talent drive knowledge creation at A*STAR research institutes. The Agency also sends scholars for undergraduate, graduate and post-doctoral training in the best universities. The Biomedical Research Council (BMRC) oversees the development of core research capabilities within A*STAR research units specialising in bioprocessing; chemical synthesis; genomics and proteomics; molecular and cell biology; bioengineering and nanotechnology and computational biology. Through competitive grants, the Council also supports research in the wider scientific community such as public universities and hospitals. As part of its efforts to advance human healthcare, BMRC actively promotes translational medicine and cross-disciplinary research. The Council also engages in human capital development in the biomedical sciences and promotes societal awareness of biomedical research through outreach programmes. For more information, please visit http://www.a-star.edu.sg

Bio*One Capital Bio*One Capital Pte Ltd is a leading, dedicated biomedical sciences investment management company in Asia with a worldwide presence. With funds of over USD 600 million, investments are focused on promising global biomedical companies where Bio*One Capital can play a value adding role in bridging and supporting companies' growth strategies in Asia through their operations in Singapore. Bio*One Capital offers a strong combination of financial, business, scientific and investment know-how to enhance the value of companies from intellectual property generating research, to clinical and product development, manufacturing and commercial activities. Through its extensive networks with global pharmaceutical, biotechnology, medical technology companies and venture capital corporations, Bio*One Capital proactively facilitates partnering and collaborative opportunities to help its portfolio companies grow into sustainable and successful ventures. For more information, please visit www.bio1capital.com